Cargando…
Identification of lactoferrin-derived peptides as potential inhibitors against the main protease of SARS-CoV-2
COVID-19 is a global health emergency that causes serious concerns. A global effort is underway to identify drugs for the treatment of COVID-19. One possible solution to the present problem is to develop drugs that can inhibit SARS-CoV-2 main protease (M(pro)), a coronavirus protein that been consid...
Autores principales: | Zhao, Wenzhu, Li, Xin, Yu, Zhipeng, Wu, Sijia, Ding, Long, Liu, Jingbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537974/ https://www.ncbi.nlm.nih.gov/pubmed/34720187 http://dx.doi.org/10.1016/j.lwt.2021.112684 |
Ejemplares similares
-
Identification of nut protein-derived peptides against SARS-CoV-2 spike protein and main protease
por: Zhao, Wenzhu, et al.
Publicado: (2021) -
Identification of tuna protein-derived peptides as potent SARS-CoV-2 inhibitors via molecular docking and molecular dynamic simulation
por: Yu, Zhipeng, et al.
Publicado: (2021) -
A cyclic peptide inhibitor of the SARS-CoV-2 main protease
por: Kreutzer, Adam G., et al.
Publicado: (2021) -
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020) -
Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
por: Hemmati, Seyed Ali, et al.
Publicado: (2022)